Capitol Health Ltd (ASX: CAJ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Capitol Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$325.14 million
P/E Ratio
51.69
Dividend Yield
3.28%
Shares Outstanding
1.07 billion
Earnings per share
0.006
Dividend per share
0.01
Year To Date Return
31.91%
Earnings Yield
1.93%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Capitol Health Ltd (ASX: CAJ)
Latest News
Share Gainers
Why these three ASX All Ords stocks are leading the charge higher this week
Share Gainers
Why Capitol Health, Infratil, Newmont, and Race Oncology shares are charging higher
Share Gainers
Why Capitol Health, Capricorn Metals, Credit Clear, and Telix shares are storming higher
Healthcare Shares
This ASX All Ords stock is rocketing 20% after accepting a takeover offer
Healthcare Shares
Buy this cheap small-cap ASX share for a very big return
Broker Notes
9 ASX shares Goldman Sachs tips to positively surprise this earnings season
Broker Notes
Top brokers name 3 ASX shares to buy today
Investing Strategies
The disappointing ASX sector now ready for a MASSIVE winter revival
Share Fallers
Why Bega Cheese, Capitol Health, Centaurus Metals, and Seek shares are falling
Healthcare Shares
Goldman Sachs has just slapped buy ratings on these ASX healthcare shares
Healthcare Shares
'Highly sought-after': 3 ASX healthcare shares ready to roar again
Healthcare Shares
79% upside: The 'frustrating' ASX share waiting to take off
Frequently Asked Questions
-
Yes, Capitol Health has historically paid two fully franked shareholder dividends a year.
-
Capitol Health generally pays its dividends in April and October.
-
Capitol Health Ltd listed on the ASX on 9 June 2006.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 06 Mar 2024 | $0.0050 | 100.00% | Interim | 02 Apr 2024 |
| 21 Sep 2023 | $0.0050 | 100.00% | Final | 20 Oct 2023 |
| 01 Mar 2023 | $0.0050 | 100.00% | Interim | 31 Mar 2023 |
| 21 Sep 2022 | $0.0050 | 100.00% | Final | 21 Oct 2022 |
| 03 Mar 2022 | $0.0050 | 100.00% | Interim | 01 Apr 2022 |
| 23 Sep 2021 | $0.0050 | 100.00% | Final | 22 Oct 2021 |
| 04 Mar 2021 | $0.0050 | 100.00% | Interim | 01 Apr 2021 |
| 24 Sep 2020 | $0.0050 | 100.00% | Final | 23 Oct 2020 |
| 05 Mar 2020 | $0.0050 | 100.00% | Interim | 23 Oct 2020 |
| 24 Sep 2019 | $0.0050 | 100.00% | Final | 23 Oct 2019 |
| 05 Mar 2019 | $0.0050 | 100.00% | Interim | 03 Apr 2019 |
| 26 Sep 2018 | $0.0040 | 100.00% | Final | 25 Oct 2018 |
| 02 Mar 2018 | $0.0040 | 100.00% | Interim | 03 Apr 2018 |
| 24 Sep 2014 | $0.0050 | 100.00% | Final | 24 Oct 2014 |
| 24 Mar 2014 | $0.0040 | 100.00% | Interim | 24 Apr 2014 |
| 23 Sep 2013 | $0.0030 | 100.00% | Final | 25 Oct 2013 |
| 22 Mar 2013 | $0.0025 | 100.00% | Interim | 26 Apr 2013 |
| 24 Sep 2012 | $0.0020 | 100.00% | Final | 19 Oct 2012 |
| 04 Apr 2012 | $0.0020 | 100.00% | Interim | 20 Apr 2012 |
CAJ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Capitol Health Ltd
Capitol Health Ltd (ASX: CAJ) is a provider of diagnostic imaging and related services to the Australian healthcare market. It oversees a network of around 60 medical imaging clinics around the country. The company's services include X-rays, ultrasounds, CT scans and MRIs, nuclear medicine, mammography/breast screening, bone densitometry, and other related services.
CAJ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 25 Jul 2024 | $0.31 | $0.00 | 0.00% | 2,105,985 | $0.31 | $0.31 | $0.30 |
| 24 Jul 2024 | $0.31 | $-0.01 | -3.23% | 1,111,424 | $0.31 | $0.31 | $0.30 |
| 23 Jul 2024 | $0.31 | $0.01 | 3.28% | 2,918,369 | $0.31 | $0.32 | $0.31 |
| 22 Jul 2024 | $0.31 | $-0.01 | -3.23% | 1,020,176 | $0.31 | $0.31 | $0.31 |
| 19 Jul 2024 | $0.31 | $0.02 | 6.78% | 8,114,778 | $0.31 | $0.32 | $0.31 |
| 18 Jul 2024 | $0.30 | $0.00 | 0.00% | 305,405 | $0.30 | $0.31 | $0.30 |
| 17 Jul 2024 | $0.30 | $0.01 | 3.45% | 1,051,329 | $0.30 | $0.30 | $0.30 |
| 16 Jul 2024 | $0.29 | $-0.01 | -3.33% | 610,092 | $0.30 | $0.30 | $0.29 |
| 15 Jul 2024 | $0.30 | $0.01 | 3.39% | 424,233 | $0.30 | $0.30 | $0.30 |
| 12 Jul 2024 | $0.30 | $-0.01 | -3.33% | 459,863 | $0.30 | $0.30 | $0.30 |
| 11 Jul 2024 | $0.30 | $0.00 | 0.00% | 6,868,302 | $0.30 | $0.31 | $0.30 |
| 10 Jul 2024 | $0.30 | $0.01 | 3.39% | 216,096 | $0.30 | $0.30 | $0.30 |
| 09 Jul 2024 | $0.30 | $-0.01 | -3.33% | 10,742,734 | $0.30 | $0.30 | $0.30 |
| 08 Jul 2024 | $0.30 | $-0.01 | -3.23% | 1,481,248 | $0.31 | $0.31 | $0.30 |
| 05 Jul 2024 | $0.31 | $0.00 | 0.00% | 367,931 | $0.31 | $0.31 | $0.31 |
| 04 Jul 2024 | $0.31 | $0.00 | 0.00% | 2,599,635 | $0.31 | $0.31 | $0.31 |
| 03 Jul 2024 | $0.31 | $0.01 | 3.28% | 2,099,271 | $0.31 | $0.31 | $0.30 |
| 02 Jul 2024 | $0.31 | $0.01 | 3.33% | 1,044,110 | $0.31 | $0.31 | $0.30 |
| 01 Jul 2024 | $0.30 | $-0.02 | -6.35% | 1,754,926 | $0.32 | $0.32 | $0.30 |
| 28 Jun 2024 | $0.32 | $0.01 | 3.23% | 2,174,227 | $0.31 | $0.32 | $0.31 |
| 27 Jun 2024 | $0.31 | $0.01 | 3.28% | 2,924,847 | $0.31 | $0.31 | $0.30 |
| 26 Jun 2024 | $0.31 | $0.01 | 3.33% | 2,598,407 | $0.31 | $0.31 | $0.30 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Nov 2023 | Justin Walter | Issued | 2,651,653 | $530,330 |
Issue of securities. 6,996,657 Unquoted Performance Rights
|
| 28 Aug 2023 | Justin Walter | Cancelled | 679,237 | $152,828 |
Cancellation of securities. 4,345,004 unquoted Performance Rights
|
| 28 Aug 2023 | Justin Walter | Buy | 2,286,865 | $514,544 |
Conversion of securities.
|
| 28 Aug 2023 | Justin Walter | Exercise | 2,286,865 | $514,544 |
Conversion of securities. 50,24,241 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Andrew Demetriou | Non-Executive ChairmanNon-Executive Director | Nov 2014 |
Mr Demetriou was Chief Executive Officer of the Australian Football League from 2003 until June 2014. He was the Managing Director of the Ruthinium Group, a dental implant business, and he currently remains a board member. Andrew has also served as Non-Executive Chairman of the Baxter Group, is a former Chairman of the Australian Multicultural Advisory Council.
|
| Mr Justin Samuel Walter | Chief Executive OfficerManaging Director | Jul 2019 |
Mr Walter has over thirty years' wealth of experience in healthcare across public and private hospitals, GP and allied health clinics, and consulting along with management and leadership skills. He was Managing Director of ASX listed healthcare company Zenitas Healthcare, and has held senior roles managing hospitals for Healthscope, and Spotless Group's health sector.
|
| Ms Laura Nicole McBain | Non-Executive Director | Jul 2021 |
Ms McBain joined Capitol Health with leadership experience having held roles of CEO / General Manager at Bellamy's Australia Limited, Managing Director of Maggie Beer Holdings Limited and Non-Executive Director of Export Finance Australia. She is currently Interim Managing Director and CEO for Lark Distilling Ltd and was a Non-executive Director from June 2020 to February 2022.
|
| Mr Richard John Loveridge | Non-Executive Director | Sep 2017 |
Mr Loveridge served as a partner in the Corporate Group of Herbert Smith Freehills for more than 20 years and was Managing Partner of their National Corporate Group for 5 years. His experience includes capital raisings, mergers and acquisitions, joint ventures, shareholder agreements, company reorganisations, and corporate head office and advisory matters.
|
| Dr Kevin (Kai-Chung) Shaw | Non-Executive Director | Sep 2021 |
Dr Shaw has training and experience in neuroradiology and musculoskeletal imaging. He is the current Director of Radiology and Nuclear Medicine atthe University Hospital, Barwon Health. He has completed his radiology training at Royal Melbourne Hospital. He is a past examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) and previously sat on the College's Anatomy Exam Review Panel.
|
| Ms Melanie Jaye Leydin | Company Secretary | Aug 2017 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| National Nominees Limited | 23,105,315 | 30.12% |
| Citicorp Nominees Pty Limited | 10,927,990 | 14.24% |
| J P Morgan Nominees Australia Pty Limited | 9,215,795 | 12.01% |
| HSBC Custody Nominees (Australia) Limited | 6,946,992 | 9.05% |
| BNP Paribas Noms Pty Ltd <Drp> | 3,100,000 | 4.04% |
| Washington H Soul Pattinson And Company Limited | 2,230,924 | 2.91% |
| Idinoc Pty Ltd <J & R Conidi Family A/C> | 2,162,897 | 2.82% |
| Buttonwood Nominees Pty Ltd | 1,677,223 | 2.19% |
| Neweconomy Com Au Nominees Pty Limited <900 Account> | 1,506,011 | 1.96% |
| Nick Conidi Pty Ltd <Conidi Family A/C> | 1,462,864 | 1.91% |
| Gia Chau Pty Ltd | 1,300,000 | 1.69% |
| SMKA Super Pty Ltd <Sk Super Fund A/C> | 1,129,113 | 1.47% |
| BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> | 1,031,055 | 1.34% |
| Mr Nicola Conidi + Mrs Giannina Conidi <Nick & Jan Conidi S/F A/C> | 1,031,055 | 1.34% |
| Ilina-Taranto Holdings Pty Ltd <Ilina Taranto Family A/C> | 982,096 | 1.28% |
| Nygupta Pty Ltd <Gupta Family A/C> | 583,333 | 0.76% |
| PCJL Pty Ltd <Pcjl Family A/C> | 540,532 | 0.70% |
| Tomandtar Nominees Pty Ltd <Dobrotwir Family A/C> | 232,629 | 0.30% |
| Teleah Pty Ltd <Jr Sauvey Super Fund A/C> | 220,000 | 0.29% |
| Stelhaven Smsf Pty Ltd <Stelhaven Super Fund A/C> | 191,610 | 0.25% |
